SCHEMBL1848731

SCHEMBL1848731

CN(C)c1ccc(-c2ccc3scnc3c2)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.45
HSD17B10 Q99714 2/20 0.45
MEN1 O00255 1/20 0.45
LMNA P02545 1/20 0.45
TP53 P04637 1/20 0.45
CYP1A2 P05177 1/20 0.45
CYP3A4 P08684 1/20 0.45
MAPK1 P28482 1/20 0.45
CASP1 P29466 1/20 0.45
CASP7 P55210 1/20 0.45
KMT2A Q03164 1/20 0.45
CLK4 Q9HAZ1 1/20 0.45
FFAR1 O14842 1/20 0.45
RIPK2 O43353 5/20 0.43
KDR P35968 3/20 0.43
TGFBR1 P36897 3/20 0.43
EGFR P00533 1/20 0.43
MAPT P10636 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
FASN P49327 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6758771 0.86 APP (0.48) ALDH1A1HSD17B10MEN1MAPK1KMT2A
SCHEMBL30209107 0.86 APP (0.48) ALDH1A1HSD17B10MEN1MAPK1KMT2A
SCHEMBL28048502 0.84 ALDH1A1 (0.54) ALDH1A1HSD17B10FFAR1RIPK2KDR
SCHEMBL3303268 0.81 FFAR1 (0.42) FFAR1RIPK2KDRTGFBR1EGFR
SCHEMBL6650934 0.81 FFAR1 (0.48) ALDH1A1HSD17B10MAPK1FFAR1RIPK2
Benzo[D]Thiazole SCHEMBL27905744 0.81 ALDH1A1 (0.59) ALDH1A1HSD17B10MEN1LMNATP53
SCHEMBL13394572 0.80 PFKFB3 (0.46) FFAR1RIPK2KDRTGFBR1EGFR
SCHEMBL29478085 0.79 RIPK2 (0.60) ALDH1A1HSD17B10FFAR1RIPK2KDR
SCHEMBL927048 0.79 RIPK2 (0.60) ALDH1A1HSD17B10FFAR1RIPK2KDR
SCHEMBL13394554 0.78 ALOX5AP (0.44) ALDH1A1HSD17B10FFAR1RIPK2KDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8420052-B2 Imaging agents useful for identifying AD pathology SIEMENS MEDICAL SOLUTIONS USA, INC. (US) 2013-04-16 US disclosed
US-8420052-B2 Imaging agents useful for identifying AD pathology SIEMENS MEDICAL SOLUTIONS USA, INC. (US) 2013-04-16 US disclosed
US-8420052-B2 Imaging agents useful for identifying AD pathology SIEMENS MEDICAL SOLUTIONS USA, INC. (US) 2013-04-16 US disclosed
EP-2323697-A2 IMAGING AGENTS USEFUL FOR IDENTIFYING AD PATHOLOGY Siemens Medical Solutions USA, Inc. (US) 2011-05-25 EP disclosed
US-20100098634-A1 Imaging Agents Useful for Identifying AD Pathology SIEMENS MEDICAL SOLUTIONS USA, INC. 2010-04-22 US disclosed
US-20100098634-A1 Imaging Agents Useful for Identifying AD Pathology SIEMENS MEDICAL SOLUTIONS USA, INC. 2010-04-22 US disclosed
US-20100098634-A1 Imaging Agents Useful for Identifying AD Pathology SIEMENS MEDICAL SOLUTIONS USA, INC. 2010-04-22 US disclosed
WO-2010011964-A2 IMAGING AGENTS USEFUL FOR IDENTIFYING AD PATHOLOGY SIEMENS MEDICAL SOLUTIONS USA, INC. (US) 2010-01-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100098634-A1 Imaging Agents Useful for Identifying AD Pathology APP, APBA1, PYGB ALDH1A1 1389/4885HSD17B10 3219/4885MEN1 1127/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.